| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Modalis Therapeutics Corp
Modalis Therapeutics Corp
TSE:4883
Modalis Therapeutics Corp
Change in Working Capital
Modalis Therapeutics Corp
Change in Working Capital Peer Comparison
2160
4587
4974
2929
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Modalis Therapeutics Corp
TSE:4883
|
Change in Working Capital
¥94.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
142%
|
CAGR 10-Years
N/A
|
|
|
GNI Group Ltd
TSE:2160
|
Change in Working Capital
-¥2.8B
|
CAGR 3-Years
-183%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
|
PeptiDream Inc
TSE:4587
|
Change in Working Capital
-¥3.8B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-133%
|
CAGR 10-Years
-29%
|
|
|
Takara Bio Inc
TSE:4974
|
Change in Working Capital
-¥6.4B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-21%
|
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Change in Working Capital
¥1.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Change in Working Capital
-¥36.9m
|
CAGR 3-Years
18%
|
CAGR 5-Years
29%
|
CAGR 10-Years
17%
|
See Also
What is Modalis Therapeutics Corp's Change in Working Capital?
Change in Working Capital
94.5m
JPY
Based on the financial report for Dec 31, 2023, Modalis Therapeutics Corp's Change in Working Capital amounts to 94.5m JPY.
What is Modalis Therapeutics Corp's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
142%
Over the last year, the Change in Working Capital growth was 894%.
You don't have any saved screeners yet
